ACMA Logo

АСМА Мedical Affairs Executive Leadership Summit 2026.

LEAD. INFLUENCE. TRANSFORM.

SPONSORSHIP RESERVATIONS BEING ACCEPTED NOW. Sponsorships will be limited to 6 for this exclusive event.

Where the Future of Medical Affairs Leadership Takes Shape

The ACMA MedicalAffairsLeadershipSummit returns on April 30, 2026, following a sold-out event in 2025 that left Medical Affairs & MSL Industry Leaders wanting more.

This one-day, in-person event exclusively brings together exclusive top executives and visionary Medical Affairs leaders across the Pharmaceutical and Life Sciences Industries.


Forget 45 min didactic sessions- Focus on exchanging ideas and building relationships

Peer-Led Discussions Icon

Sit-in on Peer Led Discussions That Matter:

Get real-world insights into challenges and innovations shaping our industry and strategies that truly make a measurable impact.

Strategic Networking Icon

Strategic Networking:

Build powerful peer relationships with executives from leading companies in an environment designed for connection and collaboration.

Shape The Future Icon

Shape the Future:

An event specifically curated and designed for maximum value with actionable outcomes.


2025 Sponsors will exclusively engage with over Executive & Senior Level Leaders

Quote Icon

"Absolutely the most relevant, high-impact Medical Affairs event I've attended all year."

Quote Icon

"The speaker lineup was world-class. Every session delivered value."

Quote Icon

"This wasn't just a conference, it was a leadership experience."

Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org

Conference Discussion

Be Part Of The Solution, Not Just The Conversation

Last year's Summit brought together Medical Affairs Leaders from over 100 companies globally, featuring speakers from:

  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
THE 2026

ACMA Medical Affairs Leadership Summit Agenda:

Come away with real-world insights and strategies that will make an impact in your partnerships. Each session is comprised of 20 minute didactic presentation and 30 minute interactive exchange

1 of 7
9:15 AM

Keynote Address: Turning Hope Into Action: Lessons in Resilience from the Edge of Life

Dr. David Fajgenbaum, physician-scientist, best-selling author of Chasing My Cure, and Co-Founder of Every Cure, shares his journey from a patient given last rites five times to a leader reshaping how rare diseases are treated. By turning personal adversity into scientific discovery, he pioneered a path to curing his own Castleman disease and now leads efforts to unlock treatments for overlooked conditions. In this keynote, Dr. Fajgenbaum challenges Medical Affairs professionals to adopt the same relentless mindset: executing a mission to drive meaningful change for patients.

David Fajgenbaum, MD, MBA, MSc
9:30 AM

Crisis Management in Medical Affairs: Preparation, Response & Recovery Panel Discussion

This session explores how Medical Affairs teams navigate high-stakes crises from drug safety events and misinformation outbreaks to organizational restructures and operational disruption. Panelists will share real-world examples of managing both external and internal reputational threats while preserving scientific credibility, patient trust, and regulatory alignment. Attendees will gain actionable frameworks to proactively prepare their teams, communicate with transparency, and recover stronger

Interactive Exchange

10:00 AM

Attendees can share their distinct case examples and engage experts for precise, case-based recommendations.

Julio J Fernandez, PharmD, RPh, MBA, BCMAS
Nami Pandit, PharmD, R.Ph
Imad Haddad, PharmD
10:45 AM

Elevating Medical Affairs Leadership in the C-Suite Panel

Is your medical affairs team speaking the language of executives? This panel discussion brings leaders who have successfully championed Medical Affairs at the enterprise level to discuss how strategy is shaped, funded, and defended within the C-suite. Gain an inside look into how Medical Affairs is viewed from leadership and how to build alignment and credibility at the highest level.

Interactive Exchange

11:15 AM

Participants get to connect one-on-one with speakers to address their own case situations and obtain targeted solutions.

Qasim Ahmad, MD
Siddharth Jain, MD
Shontelle Dodson
11:45 PM
Sponsored byCognizant

Educating at the Speed of Science: How to Elevate MSLs & Educators in the Loop with Agentic AI

With the volume of scientific data accelerating, traditional education models can no longer keep pace with evolving HCP needs. This session introduces agentic AI, multi-agent systems (MAS) and systems of agent networks (SAN) that streamline evidence assessment, content creation, and omnichannel delivery.

Lestter Cruz Serrano, MD, BCMAS
1:15 PM

2026 Medical Affairs Excellence Awards, Patient Advocate

Recognizing exceptional contributions to innovation, leadership, and impact in medical affairs.

Speaker TBA
1:30 PM

Medical Affairs Leadership in Evolving Political & Regulatory Landscapes

Shifting policies, payer pressures, and geopolitical shifts continue to redefine evidence expectations, communication standards, and field engagement rules. This session unpacks the latest regulatory and political forces shaping Medical Affairs strategy.

Interactive Exchange

2:00 PM

Participants to discuss individual cases with panelists and receive specific, personalized feedback.

Shannon P. Hatch
Elizabeth Jungman
Kimberlee Trzeciak
2:45 PM

Valuation Beyond the Molecule: Why Medical Affairs Strategy Is Now a Critical Signal to Wall Street

Can Medical Affairs be used as an economic signal? Engage with a learning healthcare equity analyst that will break down how institutional investors and Wall Street evaluate pharmaceutical/biotech companies and their Medical Affairs indicators, to predict performance

Interactive Exchange

3:15 PM

Participants can pose their case-specific questions to the speakers for focused, individualized guidance.

Michael S.K. Jeong, M.D.

Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org

Be Where Strategy Happens.

Only 6 sponsors. One powerful day.

Unmatched access to the most influential medical affairs leaders in pharma, biotech, and medtech.

The ACMA Medical Affairs Leadership Summit 2026 offers an exclusive sponsorship opportunity limited to just six industry partners. Unlike traditional events, sponsors will not be separated in a distant exhibit hall, instead, they'll be embedded directly into the main event space, side-by-side with attendees and speakers for the full day.

As a sponsor, you'll gain unprecedented access to executive-level Medical Affairs decision-makers and influencers. Your team will experience:

  • A 10 x 10 booth in the central session hall, ensuring your brand is part of every conversation
  • The chance to attend all sessions, gaining firsthand insight into the challenges, strategies, and solutions shaping the future of Medical Affairs
  • Direct engagement with top-level executives, KOLs, MSL leaders, and cross-functional stakeholders
  • Meaningful relationship-building, not just networking, sponsors will hear, speak with, and learn from the field's most visionary minds in real time.
  • Prominent Logo placement on the Summit website
  • 3 Newsletter sponsor, Ad placements, 60,000 subscribers,
  • 3 Social Media Ad placements to over 1 Million followers
  • 2 Sponsor Conference Booth Passes

This is more than visibility- it's strategic immersion. Sponsors will walk away not just with leads, but with lasting connections, competitive intelligence, and direct access to the people shaping industry standards.

Spots are extremely limited. Secure your presence at the forefront of Medical Affairs innovation.

To Sponsor or Learn more about additional sponsor opportunities.

Contact: Robert Laudadio, Director of Strategic Marketing & Partnerships

Telephone: 201 819 6145

Email: robert.laudadio@acmainfo.org

ACMA Logo